Abstract
Severe sepsis is a common cause of morbidity and mortality in intensive care units [1]. When severe sepsis is associated with hypotension, the syndrome is called septic shock [2]. Depending on the subgroup of patients, mortality of septic shock ranges from 20 to 80%. Major characteristic of septic shock is cardiovascular dysfunction. The onset of septic shock is frequently associated with hypovolemia and hypotension. Fluid resuscitation often results in a hyperdynamic hemodynamic situation with low systemic vascular resistance, high cardiac output, and perpetuation of hypotension. Despite an elevated systemic oxygen delivery (DO2), maldistribution of blood flow and altered peripheral oxygen utilization contribute to cellular hypoxia, organ dysfunction, and fatal outcome. Manifold investigations suggest that excessive release of nitric oxide (NO) plays a major role in the pathogenesis of the hyperdynamic circulatory failure in septic shock.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115: 457–469
American College of Chest Physicians/Society of Critical Care Medicine (1992) Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864–874
Feng Q, Hedner T (1990) Endothelium-derived relaxing factor (EDRF) and nitric oxide (NO). II. Physiology, pharmacology and pathophysiological implications. Clin Physiol 10: 503–526
Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142
Stuehr DJ, Griffith OW (1992) Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol 65: 287–346
Valiance P, Moncada S (1993) Role of endogenous nitric oxide in septic shock. New Horizons 1: 77–86
McKenna TM, Martin FM, Chernow B, Briglia FA (1986) Vascular endothelium contributes to decreased aortic contractility in experimental sepsis. Circ Shock 19: 267–273
Gonzalez C, Fernandez A, Martin C, Moncada S, Estrada C (1992) Nitric oxide from endothelium and smooth muscle modulates responses to sympathetic nerve stimulation: Implications for endotoxin shock. Biochem Biophys Res Commun 186: 150–156
Fleming I, Julou-Schaeffer G, Gray GA, Parratt JR, Stoclet JC (1991) Evidence that an L-arginine/nitric oxide dependent elevation of tissue cyclic GMP content is involved in depression of vascular reactivity by endotoxin. Br J Pharmacol 103: 1047–1052
Rees DD, Cellek S, Palmer RM, Moncada S (1990) Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem Biophys Res Commun 173: 541–547
Fleming I, Gray GA, Julou-Schaeffer G, Parratt JR, Stoclet JC (1990) Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem Biophys Res Commun 171: 562–568
Gray GA, Julou-Schaeffer G, Oury K, Fleming I, Parratt JR, Stoclet JC (1990) A L-arginine-derived factor mediates endotoxin-induced vascular hyposensitivity to calcium. Eur J Pharmacol 191: 89–92
Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259: H1038 - H1043
Auguet M, Guillon JM, Delaflotte S, Etiemble E, Chabrier PE, Braquet P (1991) Endothelium independent protective effect of NG-monomethyl-L-arginine on endotoxin-induced alterations of vascular reactivity. Life Sci 48: 189–193
Gray GA, Schott C, Julou-Schaeffer G, Fleming I, Parratt JR, Stoclet JC (1991) The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 103: 1218–1224
Thiemermann C, Vane J (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo. Eur J Pharmacol 182: 591–595
Mehta JL, Lawson DL, Nichols WW, Mehta P (1989) Modulation of vascular tone by neutrophils: Dependence on endothelial integrity. Am J Physiol 257: H1315 - H1320
Bernard C, Szekely B, Philip I, Wollman E, Payen D, Tedgui A (1992) Activated macrophages depress the contractility of rabbitt carotids via an L-arginine/nitric oxide-dependent effector mechanism. Connection with amplified cytokine release. J Clin Invest 89: 851–860
Myers PR, Wright TF, Tanner MA, Adams HR (1992) EDRF and nitric oxide production in cultured endothelial cells: Direct inhibition by E. coli endotoxin. Am J Physiol 262: H710 - H718
Parker JL, Adams HR (1993) Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res 72: 539–551
Lorente JA, Landin L, Renes E, et al (1993) Role of nitric oxide in the hemodynamic changes of sepsis. Crit Care Med 21: 759–767
Baker CH, Sutton ET (1993) Arteriolar endothelium-dependent vasodilation occurs during endotoxin shock. Am J Physiol 264: H1118 - H1123
Kilbourn RG, Jubran A, Gross SS, et al (1990) Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132–1138
Kilbourn RG, Gross SS, Jubran A, et al (1990) NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87: 3629–3632
Kilbourn RG, Gross SS, Lodato RF, et al (1992) Inhibition of interleukin-l-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine J Natl Cancer Inst 84: 1008–1016
Kilbourn RG, Belloni P (1990) Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. J Natl Cancer Inst 82: 772–776
Klabunde RE, Ritger RC (1991) NG-monomethyl-L-arginine ( NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock. Biochem Biophys Res Commun 178: 1135–1140
Wright CE, Rees DD, Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26: 48–57
Fujioka K, Sugi K, Isago T, et al (1991) Thromboxane synthase inhibition and cardiopulmonary function during endotoxemia in sheep. J Appl Physiol 71: 1376–1381
Hutcheson IR, Whittle BJ, Boughton-Smith NK (1990) Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 101: 815–820
Billiar TR, Curran RD, Harbrecht BG, Stuehr DJ, Demetris AJ, Simmons RL (1990) Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrate/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 48: 565–569
Shultz PJ, Raij L (1992) Endogenously synthesized nitric oxide prevents endotoxininduced glomerular thrombosis. J Clin Invest 90: 1718–1725
Meyer J, Traber LD, Nelson S, et al (1992) Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73: 324–328
Meyer J, Traber LD, Nelson S, et al (1992) Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73: 324–328
Meyer J, Stothert JC, Pollard V, Hinder F, Herndon DN, Traber DL (1993) Increased organ blood flow in sepsis and its reversal with the nitric oxide synthesis inhibitor L-NAME. Crit Care Med 21: S280 (Abst)
Teale DM, Atkinson AM (1992) Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 30: 839–842
Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471–1477
Brady AJ, Poole Wilson PA, Harding SE, Warren JB (1992) Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263: H1963 - H1966
de Belder AJ, Radomski MW, Why HJ, et al (1993) Nitric oxide synthase activities in human myocardium. Lancet 341: 84–85
Schulz R, Nava E, Moncada S (1992) Induction and potential biological relevance of a Ca’ -independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575–580
Brady AJ, Warren JB, Poole Wilson PA, Williams TJ, Harding SE (1993) Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265: H176 - H182
Klabunde RE, Ritger RC, Helgren MC (1991) Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs. Eur J Pharmacol 199: 51–59
Kubes P, Granger DN (1992) Nitric oxide modulates microvascular permeability. Am J Physiol 262: H611 - H615
Kubes P (1992) Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 262: G1138 - G1142
Kurose I, Kubes P, Wolf R, et al (1993) Inhibition of nitric oxide production. Mechanism of vascular albumin leakage. Circ Res 73: 164–171
Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P (1993) Nitric oxide prevents leukocyte adherence: Role of superoxide. Am J Physiol 265: H862 - H867
Payne D, Kubes P (1993) Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol 265: G189 - G195
Payne D, Kubes P (1993) Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol 265: G189 - G195
Hinder F, Meyer J, Nakazawa H, Traber LD, Traber DL (1993) Inhibition of nitric oxide synthase during chronic endotoxemia does not increase lung microvascular permeability to protein. Anesthesiology 79: A229 (Abst)
Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997–1000
Sakai N, Milstien S (1993) Availability of tetrahydropterin is not a factor in the inability to detect nitric oxide production by human macrophages. Biochem Biophys Res Commun 193: 378–383
Schneemann M, Schoedon G, Hofer S, Blau N, Guerro L, Schaffner A (1967) Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 167: 1358–1363
Bermudez LE (1993) Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin Exp Immunol 91: 277–281
Keller R, Keist R, Erb P, et al (1990) Expression of cellular effector functions and production of reactive nitrogen intermediates: A comparative study including T lymphocytes, T-like cells, neutrophil granulocytes, and mononuclear phagocytes. Cell Immunol 131: 398–403
Shi Y, Li HQ, Shen CK, et al (1993) Plasma nitrite levels in newborn infants with sepsis. J Pediatr 123: 435–438
Ochoa JB, Udekwu AO, Billiar TR, et al (1991) Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg. 214: 621–626
Hibbs JB, Westenfelder C, Taintor R, et al (1992) Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89: 867–877
Schneider F, Lutun P, Hasselmann M, Stoclet JC, Tempe JD (1992) Methylene blue increases systemic vascular resistance in human septic shock. Intensive Care Med 18: 309–311
Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 338: 1557–1558
Griffiths M (1993) Conference — NO business. Lancet 341: 364–365
Schilling J, Cakmakci M, Bättig U, Geroulanos S (1993) A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthetase. Intensive Care Med 19: 227–231
Lorente JA, Landin L, De Pablo R, Renes E, Liste D (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21: 1287–1295
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Meyer, J., Hinder, F., Traber, D.L. (1994). Nitric Oxide Synthase Inhibition in Septic Shock. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 1994. Yearbook of Intensive Care and Emergency Medicine 1994, vol 1994. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85068-4_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-85068-4_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-57613-6
Online ISBN: 978-3-642-85068-4
eBook Packages: Springer Book Archive